Literature DB >> 30704878

Metformin use in polycystic ovary syndrome pregnancy impacts on offspring obesity.

David H Abbott1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30704878      PMCID： PMC8131036          DOI： 10.1016/S2352-4642(19)30001-X

Source DB:  PubMed          Journal:  Lancet Child Adolesc Health        ISSN： 2352-4642


× No keyword cloud information.
  15 in total

1.  Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.

Authors:  Samantha C Fisch; Ariella Farzan Nikou; Elizabeth A Wright; Julia D Phan; Karen L Leung; Tristan R Grogan; David H Abbott; Gregorio D Chazenbalk; Daniel A Dumesic
Journal:  Fertil Steril       Date:  2018-12       Impact factor: 7.329

2.  SMFM Statement: Pharmacological treatment of gestational diabetes.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2018-02-02       Impact factor: 8.661

3.  Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.

Authors:  Nicolás Crisosto; Bárbara Echiburú; Manuel Maliqueo; Virginia Pérez; Amanda Ladrón de Guevara; Jessica Preisler; Fernando Sánchez; Teresa Sir-Petermann
Journal:  Fertil Steril       Date:  2011-11-14       Impact factor: 7.329

4.  The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus.

Authors:  Donald R Coustan; Lynn P Lowe; Boyd E Metzger; Alan R Dyer
Journal:  Am J Obstet Gynecol       Date:  2010-06       Impact factor: 8.661

5.  Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.

Authors:  C J Glueck; Ping Wang; Suichi Kobayashi; Harvey Phillips; Luann Sieve-Smith
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

6.  Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

Authors:  E Vanky; K A Salvesen; R Heimstad; K J Fougner; P Romundstad; S M Carlsen
Journal:  Hum Reprod       Date:  2004-06-03       Impact factor: 6.918

7.  Metformin versus insulin for the treatment of gestational diabetes.

Authors:  Janet A Rowan; William M Hague; Wanzhen Gao; Malcolm R Battin; M Peter Moore
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

8.  AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.

Authors:  Michael W O'Reilly; Punith Kempegowda; Mark Walsh; Angela E Taylor; Konstantinos N Manolopoulos; J William Allwood; Robert K Semple; Daniel Hebenstreit; Warwick B Dunn; Jeremy W Tomlinson; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

9.  Polycystic ovary syndrome and risk factors for gestational diabetes.

Authors:  Sanna Mustaniemi; Marja Vääräsmäki; Johan G Eriksson; Mika Gissler; Hannele Laivuori; Hilkka Ijäs; Aini Bloigu; Eero Kajantie; Laure Morin-Papunen
Journal:  Endocr Connect       Date:  2018-06-01       Impact factor: 3.335

Review 10.  A review of current treatment strategies for gestational diabetes mellitus.

Authors:  Kristi W Kelley; Dana G Carroll; Allison Meyer
Journal:  Drugs Context       Date:  2015-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.